These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 17520664)

  • 1. Changes in osteoblast, chondrocyte, and adipocyte lineages mediate the bone anabolic actions of PTH and small molecule GSK-3 inhibitor.
    Kulkarni NH; Wei T; Kumar A; Dow ER; Stewart TR; Shou J; N'cho M; Sterchi DL; Gitter BD; Higgs RE; Halladay DL; Engler TA; Martin TJ; Bryant HU; Ma YL; Onyia JE
    J Cell Biochem; 2007 Dec; 102(6):1504-18. PubMed ID: 17520664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Climbing exercise enhances osteoblast differentiation and inhibits adipogenic differentiation with high expression of PTH/PTHrP receptor in bone marrow cells.
    Menuki K; Mori T; Sakai A; Sakuma M; Okimoto N; Shimizu Y; Kunugita N; Nakamura T
    Bone; 2008 Sep; 43(3):613-20. PubMed ID: 18567552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a PTH regulated gene selectively induced in vivo during PTH-mediated bone formation.
    Robinson JA; Susulic V; Liu YB; Taylor C; Hardenburg J; Gironda V; Zhao W; Kharode Y; McLarney S; Bai Y; Malone DP; Murrills R; Bex F
    J Cell Biochem; 2006 Aug; 98(5):1203-20. PubMed ID: 16514668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skeletal unloading alleviates the anabolic action of intermittent PTH(1-34) in mouse tibia in association with inhibition of PTH-induced increase in c-fos mRNA in bone marrow cells.
    Tanaka S; Sakai A; Tanaka M; Otomo H; Okimoto N; Sakata T; Nakamura T
    J Bone Miner Res; 2004 Nov; 19(11):1813-20. PubMed ID: 15476581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intermittent treatment with parathyroid hormone (PTH) as well as a non-peptide small molecule agonist of the PTH1 receptor inhibits adipocyte differentiation in human bone marrow stromal cells.
    Rickard DJ; Wang FL; Rodriguez-Rojas AM; Wu Z; Trice WJ; Hoffman SJ; Votta B; Stroup GB; Kumar S; Nuttall ME
    Bone; 2006 Dec; 39(6):1361-72. PubMed ID: 16904389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of glycogen synthase kinase-3beta attenuates glucocorticoid-induced bone loss.
    Wang FS; Ko JY; Weng LH; Yeh DW; Ke HJ; Wu SL
    Life Sci; 2009 Nov; 85(19-20):685-92. PubMed ID: 19782693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of low-dose, intermittent treatment with recombinant human parathyroid hormone (1-34) on chondrogenesis in a model of experimental fracture healing.
    Nakazawa T; Nakajima A; Shiomi K; Moriya H; Einhorn TA; Yamazaki M
    Bone; 2005 Nov; 37(5):711-9. PubMed ID: 16143574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parathyroid hormone exerts disparate effects on osteoblast differentiation depending on exposure time in rat osteoblastic cells.
    Ishizuya T; Yokose S; Hori M; Noda T; Suda T; Yoshiki S; Yamaguchi A
    J Clin Invest; 1997 Jun; 99(12):2961-70. PubMed ID: 9185520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Daily treatment of aged ovariectomized rats with human parathyroid hormone (1-84) for 12 months reverses bone loss and enhances trabecular and cortical bone strength.
    Fox J; Miller MA; Newman MK; Metcalfe AF; Turner CH; Recker RR; Smith SY
    Calcif Tissue Int; 2006 Oct; 79(4):262-72. PubMed ID: 16969596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The anabolic action of intermittent PTH in combination with cathepsin K inhibitor or alendronate differs depending on the remodeling status in bone in ovariectomized mice.
    Yamane H; Sakai A; Mori T; Tanaka S; Moridera K; Nakamura T
    Bone; 2009 Jun; 44(6):1055-62. PubMed ID: 19303837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orally bioavailable GSK-3alpha/beta dual inhibitor increases markers of cellular differentiation in vitro and bone mass in vivo.
    Kulkarni NH; Onyia JE; Zeng Q; Tian X; Liu M; Halladay DL; Frolik CA; Engler T; Wei T; Kriauciunas A; Martin TJ; Sato M; Bryant HU; Ma YL
    J Bone Miner Res; 2006 Jun; 21(6):910-20. PubMed ID: 16753022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EphrinB2 regulation by PTH and PTHrP revealed by molecular profiling in differentiating osteoblasts.
    Allan EH; Häusler KD; Wei T; Gooi JH; Quinn JM; Crimeen-Irwin B; Pompolo S; Sims NA; Gillespie MT; Onyia JE; Martin TJ
    J Bone Miner Res; 2008 Aug; 23(8):1170-81. PubMed ID: 18627264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteogenic growth peptide C-terminal pentapeptide [OGP(10-14)] acts on rat bone marrow mesenchymal stem cells to promote differentiation to osteoblasts and to inhibit differentiation to adipocytes.
    Chen ZX; Chang M; Peng YL; Zhao L; Zhan YR; Wang LJ; Wang R
    Regul Pept; 2007 Jul; 142(1-2):16-23. PubMed ID: 17331598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycogen synthase kinase-3α/β inhibition promotes in vivo amplification of endogenous mesenchymal progenitors with osteogenic and adipogenic potential and their differentiation to the osteogenic lineage.
    Gambardella A; Nagaraju CK; O'Shea PJ; Mohanty ST; Kottam L; Pilling J; Sullivan M; Djerbi M; Koopmann W; Croucher PI; Bellantuono I
    J Bone Miner Res; 2011 Apr; 26(4):811-21. PubMed ID: 20939016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of continuous dexamethasone treatment on differentiation capabilities of bone marrow-derived mesenchymal cells.
    Oshina H; Sotome S; Yoshii T; Torigoe I; Sugata Y; Maehara H; Marukawa E; Omura K; Shinomiya K
    Bone; 2007 Oct; 41(4):575-83. PubMed ID: 17690025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parathyroid hormone 1-34 inhibits terminal differentiation of human articular chondrocytes and osteoarthritis progression in rats.
    Chang JK; Chang LH; Hung SH; Wu SC; Lee HY; Lin YS; Chen CH; Fu YC; Wang GJ; Ho ML
    Arthritis Rheum; 2009 Oct; 60(10):3049-60. PubMed ID: 19790062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like growth factor I effect on the number of osteoblast progenitors is impaired in ovariectomized mice.
    Kasukawa Y; Stabnov L; Miyakoshi N; Baylink DJ; Mohan S
    J Bone Miner Res; 2002 Sep; 17(9):1579-87. PubMed ID: 12211427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intermittent administration of human parathyroid hormone enhances bone formation and union at the site of cancellous bone osteotomy in normal and ovariectomized rats.
    Nozaka K; Miyakoshi N; Kasukawa Y; Maekawa S; Noguchi H; Shimada Y
    Bone; 2008 Jan; 42(1):90-7. PubMed ID: 17997377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SOST is a target gene for PTH in bone.
    Keller H; Kneissel M
    Bone; 2005 Aug; 37(2):148-58. PubMed ID: 15946907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intermittent administration of parathyroid hormone (1-34) stimulates matrix metalloproteinase-9 (MMP-9) expression in rat long bone.
    McClelland P; Onyia JE; Miles RR; Tu Y; Liang J; Harvey AK; Chandrasekhar S; Hock JM; Bidwell JP
    J Cell Biochem; 1998 Sep; 70(3):391-401. PubMed ID: 9706876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.